4.09
Edap Tms Sa Adr stock is traded at $4.09, with a volume of 85,071.
It is down -0.97% in the last 24 hours and up +0.49% over the past month.
Edap TMS SA, formerly known as FocalTherics, operates in the Robotic Focal Therapy industry. It develops, manufactures, and markets minimally invasive medical devices across various countries to treat various conditions using proprietary focused ultrasound technology. The company's flagship platform, Focal One Robotic HIFU, combines imaging, real-time treatment planning, robotic precision, and high intensity focused ultrasound (HIFU) technology. It is focused on expanding the clinical adoption of its patented focused ultrasound-based robotic therapy platforms through continued innovation, clinical evidence generation, physician education, and various market development initiatives.
See More
Previous Close:
$4.13
Open:
$4.3
24h Volume:
85,071
Relative Volume:
1.57
Market Cap:
$193.12M
Revenue:
Net Income/Loss:
P/E Ratio:
-11.17
EPS:
-0.3662
Net Cash Flow:
$-17.48M
1W Performance:
-2.39%
1M Performance:
+0.49%
6M Performance:
+0.00%
1Y Performance:
+0.00%
Edap Tms Sa Adr Stock (FOCL) Company Profile
Name
Edap Tms Sa Adr
Sector
Industry
Phone
33672643508
Address
PARC D'ACTIVITES LA POUDRETTE LAMARTINE, 69120 VAULX EN VELIN
Compare FOCL vs MCK, COR, CAH, HSIC, AHG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
FOCL
Edap Tms Sa Adr
|
4.09 | 193.12M | 0 | 0 | -17.48M | -0.3662 |
|
MCK
Mckesson Corp
|
1,004.84 | 117.15B | 403.43B | 5.10B | 5.41B | 38.47 |
|
COR
Cencora Inc
|
340.92 | 65.06B | 328.68B | 2.55B | 1.56B | 13.03 |
|
CAH
Cardinal Health Inc
|
254.06 | 58.83B | 250.74B | 1.55B | 4.39B | 6.5398 |
|
HSIC
Henry Schein Inc
|
86.38 | 9.63B | 13.38B | 418.00M | 391.00M | 3.3112 |
|
AHG
Akso Health Group Adr
|
1.35 | 1.16B | 14.85M | -136.07M | 7.25M | -0.4726 |
Edap Tms Sa Adr Stock (FOCL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-17-26 | Initiated | Mizuho | Outperform |
| May-15-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Apr-04-25 | Downgrade | Jefferies | Buy → Hold |
| Nov-01-22 | Initiated | Jefferies | Buy |
| Apr-28-21 | Initiated | Piper Sandler | Overweight |
| Apr-15-20 | Initiated | B. Riley FBR | Buy |
| Jul-28-14 | Downgrade | Northland Capital | Outperform → Market Perform |
| Jun-16-14 | Initiated | H.C. Wainwright | Buy |
| Mar-05-13 | Initiated | Northland Capital | Outperform |
| Nov-18-10 | Reiterated | Morgan Joseph | Buy |
| Aug-20-09 | Reiterated | Roth Capital | Hold |
| Nov-24-08 | Reiterated | Roth Capital | Hold |
| Mar-26-08 | Reiterated | Roth Capital | Hold |
| Nov-09-07 | Reiterated | Roth Capital | Hold |
| Mar-16-07 | Reiterated | Roth Capital | Hold |
| Jan-24-07 | Reiterated | Roth Capital | Hold |
View All
Edap Tms Sa Adr Stock (FOCL) Latest News
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading; Flat for Week - marketscreener.com
European Equities Traded in the US as American Depositary Receipts Drop in Thursday Trading - marketscreener.com
Form 8K EDAP TMS SA For: 19 August By Investing.com - Investing.com South Africa
EDAP TMS announces closing of additional ADS sale, expects $5.6 million in proceeds - Investing.com India
EDAP TMS announces closing of additional ADS sale, expects $5.6 million in proceeds - Investing.com
Form 8K EDAP TMS SA For: 19 August By Investing.com - Investing.com India
FocalTherics Completes ADS Offering, Boosting Capital Strength - TipRanks
EDAP TMS (NASDAQ: FOCL) legal chief buys shares in ADS offering - Stock Titan
EDAP TMS (FOCL) director Fran Schulz buys 10K shares at $4.75 - Stock Titan
EDAP TMS (FOCL) director adds stake in new share offer - Stock Titan
EDAP TMS SA (FOCL) director adds 50K shares tied to ADS offering - Stock Titan
EDAP TMS (FOCL) CFO adds 5,000 shares in ADS-linked buy - Stock Titan
EDAP TMS SA -ADR (FOCL) Stock Chart - ChartMill
Form 8K EDAP TMS SA For: 14 August By Investing.com - Investing.com India
EDAP TMS raises $40M in stock offering to fund operations - Dealroom
Form 8K EDAP TMS SA For: 11 August By Investing.com - Investing.com India
FocalTherics Prices $40 Million Public Offering of American Depositary Shares - marketscreener.com
FocalTherics Sets $4.75 ADS Price; 8.4M Sale Expected to Close Aug. 14 - Stock Titan
FOCLEDAP TMS SA ADR Short Interest - Finviz
Edap TMS stock initiated at Outperform by Mizuho on HIFU outlook - Investing.com
EDAP TMS S.A. (EDAP) Holds Steady at $4.32 Amid ConsolidationMomentum Surge Alerts - dars.gov.et
EDAP TMS SA Sponsored ADR Actuals & Estimates (NASDAQ:FOCL) - TradingView
FOCL SEC FilingsEDAP TMS SA 10-K, 10-Q, 8-K Forms - Stock Titan
EDAP TMS S.A. (FOCL) Stock Price, News & Analysis - Stock Titan
EDAP TMS S.A. (ADR) (FOCL) Live Share Price, Invest From India - INDmoney
symbol__ Stock Quote Price and Forecast - CNN
FocalTherics (FOCL) Stock Price, News & Analysis $FOCL - MarketBeat
EDAP TMS (Nasdaq:FOCL)Stock Analysis - Simply Wall Street
FOCL Stock Price and Chart — NASDAQ:FOCL - TradingView
EDAP | Focal One to Host Investor Day on June 1, 2026 - Barchart.com
EDAP Announces Corporate Name Change to FocalTherics™ to - GlobeNewswire
New FocalTherics name marks EDAP’s exclusive focus on robotic focal therapy - Stock Titan
EDAP changes name to FocalTherics, new ticker FOCL June 1 - investing.com
EDAP TMS and Telix sign letter of intent for prostate cancer - Investing.com
Earnings call transcript: EDAP TMS Q1 2026 revenue beats forecast, stock jumps - Investing.com
Earnings call transcript: EDAP TMS Q1 2026 sees robust HIFU growth - Investing.com
EDAP TMS Strengthens Market Position with Landmark HIFI-2 Data Supporting Focal One® Robotic HIFU in Radiorecurrent Prostate Cancer - barchart.com
Top LosersStock ScreenerSnapshot - Finviz
EDAP reports record HIFU revenue, issues strong 2026 guidance - Investing.com
EDAP TMS S.A. (FOCL) stock price, news, quote and history - Yahoo Finance UK
Edap Tms Sa Adr Stock (FOCL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Edap Tms Sa Adr Stock (FOCL) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Rhodes Ryan | Chief Executive Officer |
Aug 14 '26 |
Buy |
4.75 |
21,000 |
99,750 |
626,649 |
| Annen Steven | SVP, Marketing & Product Mgmt. |
Aug 14 '26 |
Buy |
4.75 |
5,000 |
23,750 |
136,490 |
| Shah Sanket | General Counsel & Corp Sec |
Aug 14 '26 |
Buy |
4.75 |
5,000 |
23,750 |
72,500 |
| Schulz Fran | Director |
Aug 14 '26 |
Buy |
4.75 |
10,000 |
47,500 |
15,100 |
| LEVINE JOSHUA | Director |
Aug 14 '26 |
Buy |
4.75 |
10,000 |
47,500 |
45,000 |
| Mobeck Kenneth S. | Chief Financial Officer |
Aug 14 '26 |
Buy |
4.75 |
5,000 |
23,750 |
181,610 |
| WILLSEY LANCE | Director |
Aug 14 '26 |
Buy |
4.75 |
50,000 |
237,500 |
1,291,780 |
| LEVINE JOSHUA | Director |
May 11 '26 |
Buy |
4.22 |
10,000 |
42,200 |
35,000 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):